Cantel Medical (CMD) Tops Q2 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
- Six dead in 'stampede-like' incident at India temple, ANI says
Cantel Medical Reports Record Financial Results for its Second Quarter Fiscal Year 2018
March 8, 2018 8:00 AM ESTLITTLE FALLS, N.J., March 8, 2018 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its second quarter ended January 31, 2018.
Jørgen B. Hansen, President and Chief Executive Officer, stated, "We are pleased to report record sales and earnings performance this quarter. Our 15.3% reported sales increase was driven by organic growth of 10.0%, the impact from acquisitions of 4.2%, and a favorable impact from foreign currency of 1.1%. We continue to outperform internationally where sales were up 43.0% overall, while our US business had a strong quarter with 7.9% growth."
Financial Highlights:Endoscopy... More

